Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes
Authors' conclusion
In veterans receiving dialysis who also had diabetes, incident CGM use was associated with better survival versus non-CGM use.
Study context
- Population
- U.S. veterans receiving dialysis with diabetes, January 2012 to December 2023, followed through February 2025complete case cohort
- Participants
- 2,008 veterans
- Exposure
- Incident continuous glucose monitoring (CGM) use vs non-CGM use
- Outcome
- All-cause mortality
Methodological detailspropensity-score matched, national linked data (VA, USRDS, Medicare)
- Propensity-score matched
- National linked data (VA, USRDS, Medicare)
Main finding
As reported in the abstract
All-cause mortality (complete case analysis)
CGM use vs Non-CGM useHazard ratio (95% CI)
PS-matched unadjusted Cox model
0.86(0.76–0.98)
PS-matched doubly adjusted Cox model
0.83(0.75–0.92)
Observational data: associations, not effects.
Further findings
| Outcome | HR (95% CI) | |
|---|---|---|
| All-cause mortality (multiple imputation cohort, n = 3,088)CGM usevs Non-CGM usePS-matched unadjusted Cox model | 0.88 (0.77–0.99) | |
| All-cause mortality (multiple imputation cohort, n = 3,088)CGM usevs Non-CGM usePS-matched doubly adjusted Cox model | 0.84 (0.73–0.96) | |
| 0.512Hazard ratio (log scale) |
Original publication
Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes. Diabetes Care. Published 1 June 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →